EMBL Australia

EMBL Australia Group Leader Dr Senthil Arumugam has co-launched the Monash BDI Advanced Bioimaging (MAB) platform – a researcher-led, global collaboration hub designed to bring innovative microscopy technologies directly to the researchers who need them.

EMBL Australia researchers Dr Qi Zhang, Prof Eduardo Eyras and Daisy Kavanagh recently joined scientists from around the globe at the 5th EMBL Partnership Conference at EMBL Heidelberg to explore the role of artificial intelligence (AI) in life sciences.

We are thrilled to announce the appointment of Professor Jose Polo as the new Scientific Head of EMBL Australia.

EMBL Australia Council Chair Emeritus Professor Ian Smith, Scientific Head Professor James Whisstock and Chief Operating Officer Annette Wittmann joined more than 400 global research infrastructure (RI) experts at the 2024 International Conference on Research Infrastructures (ICRI) in Brisbane (Meanjin). 

Professor Eduardo Eyras, Associate Professor Robert Weatheritt and Professor Chen Davidovich have been awarded four Discovery Project grants, totalling more than $3 million.

Professor James Whisstock is stepping down after eight transformative years as Scientific Head of EMBL Australia. Prof. Whisstock is a structural biologist at Monash Biomedicine Discovery Institute and Deputy Dean…

EMBL Australia group leader Dr William Roman has been awarded a 2024 Metcalf Prize for Stem Cell Research for his work growing human muscles on a chip. This technology will advance disease modelling, drug screening, cellular agriculture & biorobotics.

EMBL Australia is proud to be working together with Bioplatforms Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia to keep Australians healthy through research innovation.

EMBL Australia Scientific Head Professor James Whisstock was one of the 31 newly elected Fellows of the Australian Academy of Health and Medical Sciences (AAHMS) for 2024 for his outstanding contributions to immunology.

EMBL Australia group leader Dr Qi Zhang has been awarded a prestigious fellowship to advance her epigenetics research, with the aim of generating fundamental knowledge to enable new cancer drugs.